Results 231 to 240 of about 178,738 (259)

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Lancet, The, 2021
Bon-Kwon Koo, Jeehoon Kang, Kyung Woo Park   +2 more
exaly  

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Lancet, The, 2013
Johannes C Kelder
exaly  

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

Lancet, The, 2009
C Michael Gibson
exaly  

Clopidogrel

Reactions Weekly, 2016
openaire   +2 more sources

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

Lancet, The, 2009
Jean-Philippe Collet, Jean-Sébastien Hulot, Eric Villard   +2 more
exaly  

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Lancet, The, 2009
Michelle L O'donoghue, Eugene Braunwald, Elliott M Antman   +2 more
exaly  

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Lancet, The, 2010
Marc S Sabatine
exaly  

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Lancet, The, 2009
Rikke Sørensen, Charlotte Andersson, Lars Køber   +2 more
exaly  

Clopidogrel

Reactions Weekly, 2017
  +4 more sources

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

New England Journal of Medicine, 2009
Lars Wallentin, Richard C Becker, Andrzej J Budaj   +2 more
exaly